3 hours AbbVie (NYSE:ABBV) Given New $220.00 Price Target at BMO Capital MarketsMarketBeat
BMO Capital Markets lifted their price target on AbbVie from $214.00 to $220.00 and gave the stock an “outperform” rating in a research note on Thursday.
AbbVie (ABBV) · Markets · NYSE · Science
X